Basel Medical Group Ltd (BMGL)

NASDAQ: BMGL · Real-Time Price · USD

0.6840

-1.2460 (-64.56%)

At close: Nov 11, 2026, 4:00 PM EST

0.6834

-0.0006 (-0.09%)

After-hours: Nov 11, 2026, 7:59 PM EST

Basel Medical Group Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	0.53	3.04	1.95	1.22	1.56
Short-Term Investments	-	6.77	0.09	0.1	0.1
Cash & Short-Term Investments	0.53	9.82	2.04	1.31	1.66
Cash Growth	-94.60%	380.92%	55.27%	-20.86%	-
Accounts Receivable	10.34	2.15	1.67	1.44	2.01
Other Receivables	-	0.37	0.21	1.34	0.84
Receivables	10.34	2.53	12.44	13.33	13.88
Inventory	0.23	0.49	0.07	0.09	0.07
Prepaid Expenses	-	0.43	0.03	0.04	0.05
Other Current Assets	1.03	0.03	1.59	-	-
Total Current Assets	12.13	13.29	16.17	14.77	15.67
Property, Plant & Equipment	5.6	5.34	0.06	0.58	1.18
Other Intangible Assets	-	0	-	-	-
Long-Term Deferred Tax Assets	0.06	0.05	0.08	0.03	0
Total Assets	17.79	18.68	16.31	15.38	16.85

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Accounts Payable	3.55	2.06	0.83	1.46	1.08
Accrued Expenses	-	1.72	1.47	0.31	0.89
Short-Term Debt	0.96	1.51	1.42	-	-
Current Portion of Long-Term Debt	5.27	-	2.68	3.22	3.63
Current Portion of Leases	-	2.06	0.03	0.57	0.57
Current Income Taxes Payable	0	-	0.44	0.48	0.39
Other Current Liabilities	0.08	2.81	0.3	0.43	0.63
Total Current Liabilities	9.86	10.16	7.16	6.47	7.19
Long-Term Debt	3.39	-	1.58	3.4	5.31
Long-Term Leases	-	2.96	-	0.03	0.64
Long-Term Deferred Tax Liabilities	-	0.12	-	-	-
Total Liabilities	13.25	13.24	8.75	9.89	13.14

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Common Stock	34.21	34.21	24.46	0	0
Retained Earnings	-4.32	-3.85	7.56	5.49	3.71
Comprehensive Income & Other	-24.83	-24.92	-24.46	-	-
Total Common Equity	5.06	5.43	7.56	5.49	3.71
Minority Interest	-0.52	0	-	-	-
Shareholders' Equity	4.54	5.44	7.56	5.49	3.71
Total Liabilities & Equity	17.79	18.68	16.31	15.38	16.85

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Total Debt	9.62	6.53	5.71	7.21	10.15
Net Cash (Debt)	-9.09	3.29	-3.67	-5.9	-8.49
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-5.75	2.10	-2.71	-4.36	-6.27
Filing Date Shares Outstanding	1.6	1.58	1.35	1.35	1.35
Total Common Shares Outstanding	1.6	1.57	1.35	1.35	1.35
Working Capital	2.27	3.13	9.01	8.31	8.47
Book Value Per Share	3.16	3.47	5.58	4.05	2.74
Tangible Book Value	5.06	5.43	7.56	5.49	3.71
Tangible Book Value Per Share	3.16	3.47	5.58	4.05	2.74
Machinery	-	1.75	0.64	0.63	0.62

SEC Filings: 10-K · 10-Q